Skip to main content


The Section of Hepatopancreatobiliary (HPB) Surgery is dedicated to pioneering new treatments for pancreas, liver, sarcoma, and peritoneal cancer through basic and clinical research.

Our Surgical Oncology Research Group meets regularly to discuss the latest areas of investigation in the field, and we present frequently at national meetings.

Through ongoing research and clinical trials, we aim to improve outcomes. As part of the National Comprehensive Cancer Network, we belong to an alliance of the country’s top cancer centers committed to improving patient care, research, and education.

Recent research projects include:

  • Pancreatic cancer registry: Optimizing efficacy of multimodality therapies for pancreatic cancer
  • Immune system’s response in pancreatic cancer
  • Role of surgery in metastatic pancreatic cancer
  • Enhanced recovery with minimally invasive surgery after pancreaticoduodenectomy (Whipple)
  • Liver registry
  • Discovery of novel therapeutic strategies for cholangiocarcinoma: We apply high throughput, unbiased techniques to study functional genomics and molecular signaling pathways in cholangiocarcinoma, so as to identify tumor-specific dependencies, novel therapeutic agents, and/or targetable pathways, ultimately translating into clinical trials and improved patient outcomes.

Clinical Trials

Our faculty are active in clinical trials to improve HPB treatments. These include:


Dr. Allen's Recent Publications

Dr. Blazer's Recent Publications

Dr. Herbert's Recent Publications

Dr. Lidsky's Recent Publications

Dr. Pappas's Recent Publications

Dr. Shah's Recent Publications

Dr. Zani's Recent Publications